Clinical Trial

Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study

Study acronym: SED-RO-ICC
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Second-line regimen with or without consolidative radiotherapy in patients with oligometastatic/locally advanced unresectable intrahepatic cholangiocarcinoma: an open-label, randomised, controlled study.
Trial Details
NCT Number NCT06946849
Lead Sponsor Shanghai Zhongshan Hospital
Conditions Intrahepatic Cholangiocarcinoma (Icc)
Enrollment 76 participants
Start Date 2025-06-01
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-27